Organ-on-a-chip (OoC) 麻豆原创 Size, Competition and Demand Analysis Report #Insights

Publication ID:

MRRPB5#46

Publication Date:

February 6, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharma & Healthcare [2]

Healthcare [3]

IT & eHealth [4]

Medical Devices [5]

Pharma & Healthcare Technology [6]

Research & Development (Pharma & Healthcare) [7]

Description:

An organ-on-a-chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics, and physiological response of entire organs and organ systems, a type of artificial organ. Organ-on-a-chip (OoC) technology [8] has emerged as a promising platform for preclinical studies; it听constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS.

Report Highlights

The global Organs-on-chips market was valued at US$ 25810 million in 2022 and is anticipated to reach US$ 67070 million by 2029, witnessing a CAGR of 17.3% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Organs-on-chips, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Organs-on-chips.
The Organs-on-chips market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Organs-on-chips market comprehensively. Regional market sizes concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Organs-on-chips companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

By Company

听听 Emulate Inc
听听 CN Bio
听听 TissUse
听听 Mimetas
听听 Insphero
听听 Ascendance Bio
听听 Kirkstall
听听 Hurel
听听 Synvivo
听听 Axosim
听听 Nortis Bio

Segment by Type

听听 Liver-on-a-chip [9]
听听 Kidney-on-a-chip [10]
听听 Lung-on-a-chip [11]
听听 Heart-on-a-chip [12]
听听 Others

Segment by Application

听听 Physiological Model Development
听听 Drug Discovery
听听 Toxicology Research

By Region
听听 North America

听听听听 United States
听听听听 Canada

听听 Europe

听听听听 Germany
听听听听 France
听听听听 UK
听听听听 Italy
听听听听 Russia
听听听听 Nordic Countries
听听听听 Rest of Europe

听听 Asia-Pacific

听听听听 China
听听听听 Japan
听听听听 South Korea
听听听听 Southeast Asia
听听听听 India
听听听听 Australia
听听听听 Rest of Asia

听听 Latin America

听听听听 Mexico
听听听听 Brazil
听听听听 Rest of Latin America

听听 Middle East & Africa

听听听听 Turkey
听听听听 Saudi Arabia
听听听听 UAE
听听听听 Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Organs-on-chips companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries. It introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Organs-on-chips 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Liver-on-a-chip
1.2.3 Kidney-on-a-chip
1.2.4 Lung-on-a-chip
1.2.5 Heart-on-a-chip
1.2.6 Others
1.3 麻豆原创 by Application
1.3.1 Global Organs-on-chips 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Physiological Model Development
1.3.3 Drug Discovery
1.3.4 Toxicology Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Organs-on-chips 麻豆原创 Perspective (2018-2029)
2.2 Organs-on-chips Growth Trends by Region
2.2.1 Global Organs-on-chips 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Organs-on-chips Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Organs-on-chips Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Organs-on-chips 麻豆原创 Dynamics
2.3.1 Organs-on-chips Industry Trends
2.3.2 Organs-on-chips 麻豆原创 Drivers
2.3.3 Organs-on-chips 麻豆原创 Challenges
2.3.4 Organs-on-chips 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Organs-on-chips Players by Revenue
3.1.1 Global Top Organs-on-chips Players by Revenue (2018-2023)
3.1.2 Global Organs-on-chips Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Organs-on-chips 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Organs-on-chips Revenue
3.4 Global Organs-on-chips 麻豆原创 Concentration Ratio
3.4.1 Global Organs-on-chips 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Organs-on-chips Revenue in 2022
3.5 Organs-on-chips Key Players Head office and Area Served
3.6 Key Players Organs-on-chips Product Solution and Service
3.7 Date of Enter into Organs-on-chips 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Organs-on-chips Breakdown Data by Type
4.1 Global Organs-on-chips Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Organs-on-chips Forecasted 麻豆原创 Size by Type (2024-2029)
5 Organs-on-chips Breakdown Data by Application
5.1 Global Organs-on-chips Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Organs-on-chips Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Organs-on-chips 麻豆原创 Size (2018-2029)
6.2 North America Organs-on-chips 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Organs-on-chips 麻豆原创 Size by Country (2018-2023)
6.4 North America Organs-on-chips 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Organs-on-chips 麻豆原创 Size (2018-2029)
7.2 Europe Organs-on-chips 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Organs-on-chips 麻豆原创 Size by Country (2018-2023)
7.4 Europe Organs-on-chips 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Organs-on-chips 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Organs-on-chips 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Organs-on-chips 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Organs-on-chips 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Organs-on-chips 麻豆原创 Size (2018-2029)
9.2 Latin America Organs-on-chips 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Organs-on-chips 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Organs-on-chips 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Organs-on-chips 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Organs-on-chips 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Organs-on-chips 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Organs-on-chips 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Emulate Inc
11.1.1 Emulate Inc Company Detail
11.1.2 Emulate Inc Business Overview
11.1.3 Emulate Inc Organs-on-chips Introduction
11.1.4 Emulate Inc Revenue in Organs-on-chips Business (2018-2023)
11.1.5 Emulate Inc Recent Development
11.2 CN Bio
11.2.1 CN Bio Company Detail
11.2.2 CN Bio Business Overview
11.2.3 CN Bio Organs-on-chips Introduction
11.2.4 CN Bio Revenue in Organs-on-chips Business (2018-2023)
11.2.5 CN Bio Recent Development
11.3 TissUse
11.3.1 TissUse Company Detail
11.3.2 TissUse Business Overview
11.3.3 TissUse Organs-on-chips Introduction
11.3.4 TissUse Revenue in Organs-on-chips Business (2018-2023)
11.3.5 TissUse Recent Development
11.4 Mimetas
11.4.1 Mimetas Company Detail
11.4.2 Mimetas Business Overview
11.4.3 Mimetas Organs-on-chips Introduction
11.4.4 Mimetas Revenue in Organs-on-chips Business (2018-2023)
11.4.5 Mimetas Recent Development
11.5 Insphero
11.5.1 Insphero Company Detail
11.5.2 Insphero Business Overview
11.5.3 Insphero Organs-on-chips Introduction
11.5.4 Insphero Revenue in Organs-on-chips Business (2018-2023)
11.5.5 Insphero Recent Development
11.6 Ascendance Bio
11.6.1 Ascendance Bio Company Detail
11.6.2 Ascendance Bio Business Overview
11.6.3 Ascendance Bio Organs-on-chips Introduction
11.6.4 Ascendance Bio Revenue in Organs-on-chips Business (2018-2023)
11.6.5 Ascendance Bio Recent Development
11.7 Kirkstall
11.7.1 Kirkstall Company Detail
11.7.2 Kirkstall Business Overview
11.7.3 Kirkstall Organs-on-chips Introduction
11.7.4 Kirkstall Revenue in Organs-on-chips Business (2018-2023)
11.7.5 Kirkstall Recent Development
11.8 Hurel
11.8.1 Hurel Company Detail
11.8.2 Hurel Business Overview
11.8.3 Hurel Organs-on-chips Introduction
11.8.4 Hurel Revenue in Organs-on-chips Business (2018-2023)
11.8.5 Hurel Recent Development
11.9 Synvivo
11.9.1 Synvivo Company Detail
11.9.2 Synvivo Business Overview
11.9.3 Synvivo Organs-on-chips Introduction
11.9.4 Synvivo Revenue in Organs-on-chips Business (2018-2023)
11.9.5 Synvivo Recent Development
11.10 Axosim
11.10.1 Axosim Company Detail
11.10.2 Axosim Business Overview
11.10.3 Axosim Organs-on-chips Introduction
11.10.4 Axosim Revenue in Organs-on-chips Business (2018-2023)
11.10.5 Axosim Recent Development
11.11 Nortis Bio
11.11.1 Nortis Bio Company Detail
11.11.2 Nortis Bio Business Overview
11.11.3 Nortis Bio Organs-on-chips Introduction
11.11.4 Nortis Bio Revenue in Organs-on-chips Business (2018-2023)
11.11.5 Nortis Bio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

听听 Emulate Inc
听听 CN Bio
听听 TissUse
听听 Mimetas
听听 Insphero
听听 Ascendance Bio
听听 Kirkstall
听听 Hurel
听听 Synvivo
听听 Axosim
听听 Nortis Bio

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.